Die expansile familiäre Osteolyse ist eine autosomal dominante Erkrankung, die durch Mutationen des TNFRSF11A-Gens hervorgerufen wird. Die Erkrankung beginnt in der zweiten Lebensdekade und ist durch progressive schmerzhafte Knochendeformitäten charakterisiert.
1. |
Hughes AE et. al. (1994) Genetic linkage of familial expansile osteolysis to chromosome 18q. |
2. |
Hughes AE et. al. (2000) Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. |
3. |
Whyte MP et. al. (2002) Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. |
4. |
Palenzuela L et. al. (2002) Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. |
5. |
Johnson-Pais TL et. al. (2003) Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. |
6. |
Elahi E et. al. (2007) Intragenic SNP haplotypes associated with 84dup18 mutation in TNFRSF11A in four FEO pedigrees suggest three independent origins for this mutation. |
7. |
Dickson GR et. al. (1991) Familial expansile osteolysis: a morphological, histomorphometric and serological study. |
8. |
Barr RJ et. al. (1989) Idiopathic multicentric osteolysis: report of two new cases and a review of the literature. |
9. |
Osterberg PH et. al. (1988) Familial expansile osteolysis. A new dysplasia. |
10. |
Whyte MP et. al. (2000) Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease. |
11. |
Daneshi A et. al. (2005) Hereditary bilateral conductive hearing loss caused by total loss of ossicles: a report of familial expansile osteolysis. |
12. |
Schafer AL et. al. (2014) Panostotic expansile bone disease with massive jaw tumor formation and a novel mutation in the signal peptide of RANK. |